🇺🇸 FDA
Patent

US 7514441

Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

granted A61PA61P13/12A61P19/00

Quick answer

US patent 7514441 (Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents) held by Takeda Pharmaceutical Company Limited expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P13/12, A61P19/00, A61P19/02, A61P19/08